Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Board Meeting to be held on 29th May 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kabra Drugs Ltd has informed BSE that a Board meeting is scheduled for 29th May 2026 at its Corporate Office in Chennai. The meeting will consider and approve the unaudited financial results for the quarter ended 31st March 2026 (Q4 FY2026), pursuant to SEBI Listing Regulation 33. The company has closed the trading window for promoters, directors, designated employees, and connected persons until 48 hours after the results announcement. This is a standard regulatory intimation filed 8 days in advance of the scheduled meeting date.
This is a routine pre-results announcement filing under SEBI regulations. No material information is being disclosed at this stage — actual financial results will be released after the board meeting on 29th May 2026.